心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2019 EHRA无症状性心律失常管理的专家共识解读

2019-11-30 中国循环杂志.2019,34(11):31-33.

无症状心律失常

无症状性心律失常在临床上十分常见，尽管其中多数为良性，部分类型仍需要适当的诊治以避免严重的后果。迄今针对无症状性心律失常的研究证据较少，2019 年3 月欧洲心律学会（EHRA）发布了《2019 EHRA 无症状性心律失常的管理专家共识》，就无症状性心律失常的定义、临床评估及诊治建议进行了较为全面的总结，为临床诊治无症状性心律失常提供了依据，本文拟对其重点内容进行解读。

中文标题：

2019 EHRA无症状性心律失常管理的专家共识解读

发布机构：

发布日期：

2019-11-30

简要介绍：

无症状性心律失常在临床上十分常见，尽管其中多数为良性，部分类型仍需要适当的诊治以避免严重的后果。迄今针对无症状性心律失常的研究证据较少，2019 年3 月欧洲心律学会（EHRA）发布了《2019 EHRA 无症状性心律失常的管理专家共识》，就无症状性心律失常的定义、临床评估及诊治建议进行了较为全面的总结，为临床诊治无症状性心律失常提供了依据，本文拟对其重点内容进行解读。

作者：阜外医院心律失常中心 姚焰

拓展指南：与心律失常相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 EHRA无症状性心律失常管理的专家共识解读)] GetToolGuiderByIdResponse(projectId=1, id=011861c0018a809b, title=2019 EHRA无症状性心律失常管理的专家共识解读, enTitle=, guiderFrom=中国循环杂志.2019,34(11):31-33., authorId=null, author=, summary=无症状性心律失常在临床上十分常见，尽管其中多数为良性，部分类型仍需要适当的诊治以避免严重的后果。迄今针对无症状性心律失常的研究证据较少，2019 年3 月欧洲心律学会（EHRA）发布了《2019 EHRA 无症状性心律失常的管理专家共识》，就无症状性心律失常的定义、临床评估及诊治建议进行了较为全面的总结，为临床诊治无症状性心律失常提供了依据，本文拟对其重点内容进行解读。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Nov 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>无症状性心律失常在临床上十分常见，尽管其中多数为良性，部分类型仍需要适当的诊治以避免严重的后果。迄今针对无症状性心律失常的研究证据较少，2019 年3 月欧洲心律学会（EHRA）发布了《2019 EHRA 无症状性心律失常的管理专家共识》，就无症状性心律失常的定义、临床评估及诊治建议进行了较为全面的总结，为临床诊治无症状性心律失常提供了依据，本文拟对其重点内容进行解读。 </P> <P>作者：阜外医院心律失常中心 姚焰</P>拓展指南：<strong>与<font color=red>心律失常</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=778411c001825aeb" title="《ACS和血运重建紧急情况下心律失常管理共识2019》解读" target=_blank>《ACS和血运重建紧急情况下心律失常管理共识2019》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0ca671c001e8a337" title="索他洛尔抗心律失常中国专家共识" target=_blank>索他洛尔抗心律失常中国专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=31a891c001e7562d" title="2019 EHRA共识：急性冠脉综合征和血运重建紧急情况下的心律失常" target=_blank>2019 EHRA共识：急性冠脉综合征和血运重建紧急情况下的心律失常</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=41a2a1c001e71220" title="2019 HRS/EHRA/APHRS/LAHR专家共识声明：导管消融治疗室性心律失常" target=_blank>2019 HRS/EHRA/APHRS/LAHR专家共识声明：导管消融治疗室性心律失常</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2a6951c001e7075f" title="2019 HRS/EHRA/APHRS/LAHR专家共识声明：导管消融治疗室性心律失常" target=_blank>2019 HRS/EHRA/APHRS/LAHR专家共识声明：导管消融治疗室性心律失常</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8" target=_blank>有关心律失常更多指南</a></ul>, tagList=[TagDto(tagId=98501, tagName=无症状心律失常)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4388, appHits=289, showAppHits=60, pcHits=2888, showPcHits=1952, likes=64, shares=28, comments=7, approvalStatus=1, publishedTime=Sun Jan 05 23:57:14 CST 2020, publishedTimeString=2019-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jan 05 23:57:14 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 02:57:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EHRA无症状性心律失常管理的专家共识解读)])
2019 EHRA无症状性心律失常管理的专家共识解读
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=962464, encodeId=f88696246428, content=看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/173fbc4a330441a0a602d38d841e7cb0/feef4c7720f04a67bf79c119fd477b6f.jpg, createdBy=6da75491593, createdName=天天向上, createdTime=Mon May 03 16:25:20 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809609, encodeId=cdbe8096090c, content=学习资料真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Mon Aug 17 09:26:54 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377844, encodeId=c0e63e78440a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jan 06 07:01:30 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
    2021-05-03 天天向上

    看不了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=962464, encodeId=f88696246428, content=看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/173fbc4a330441a0a602d38d841e7cb0/feef4c7720f04a67bf79c119fd477b6f.jpg, createdBy=6da75491593, createdName=天天向上, createdTime=Mon May 03 16:25:20 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809609, encodeId=cdbe8096090c, content=学习资料真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Mon Aug 17 09:26:54 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377844, encodeId=c0e63e78440a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jan 06 07:01:30 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
    2020-08-17 14643f34m67暂无昵称

    学习资料真好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=962464, encodeId=f88696246428, content=看不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/173fbc4a330441a0a602d38d841e7cb0/feef4c7720f04a67bf79c119fd477b6f.jpg, createdBy=6da75491593, createdName=天天向上, createdTime=Mon May 03 16:25:20 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809609, encodeId=cdbe8096090c, content=学习资料真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Mon Aug 17 09:26:54 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377844, encodeId=c0e63e78440a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jan 06 07:01:30 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
    2020-01-06 thm112988

    好

    0